caprylates has been researched along with Allergic Encephalomyelitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Amadio, S; Camponeschi, C; Clementi, ME; De Carluccio, M; Di Liddo, R; Di Sante, G; Michetti, F; Ria, F; Romano Spica, V; Sampaolese, B; Tredicine, M; Volonté, C | 1 |
1 other study(ies) available for caprylates and Allergic Encephalomyelitis
Article | Year |
---|---|
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis.
Topics: Animals; Caprylates; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Multiple Sclerosis; S100 Calcium Binding Protein beta Subunit | 2021 |